[Clinical evaluation of the use of somatostatin (VAL 787) in the treatment of upper digestive hemorrhage].

Abstract

Personal experience with 30 patients treated with Somatostatin for upper gastrointestinal bleeding is reported. The conclusion is drawn that this drug, reducing chloro-peptic secretion and hepatic portal blood flow, can reduce and control bleeding and postpone the surgical operation, which has a high rate of mortality.